Physician profile
Joseph Robert Martin
NPI 1356819312
$3,436.82
in general payments reported to CMS, 2019-2025
22 companies · $910 in 2025
The $910 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $429 · 2022: $754 · 2023: $912 · 2024: $433 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,254.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $623.47 | 2021-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $344.12 | 2022-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $344.02 | 2022-2025 | Jardiance |
| Shockwave Medical, INC | $277.81 | 2025 | |
| Pfizer INC. | $244.45 | 2021-2025 | |
| Boston Scientific Corporation | $208.10 | 2021-2025 | Bodyguardian, Opticross 35, Rotapro |
| Astrazeneca Pharmaceuticals LP | $197.34 | 2021-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $196.21 | 2021-2025 | |
| Kestra Medical Technology Services, INC. | $179.50 | 2024-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $175.18 | 2021-2024 | |
| Irhythm Technologies, INC. | $122.74 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Stryker Corporation | $105.12 | 2025 | Artix Mt, Clottriever Bold Catheter |
| Amgen INC. | $77.22 | 2021-2023 | Repatha |
| Abiomed | $66.66 | 2024-2025 | Impella |
| Itamar Medical INC | $59.02 | 2022-2024 | Watchpatone |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $49.80 | 2023-2024 | Angio-Seal, Tr Band |
| Medtronic, INC. | $45.31 | 2021-2024 | Linq II |
| Novo Nordisk INC | $30.30 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals, LTD. | $29.84 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $24.43 | 2024 | |
| Lilly USA, LLC | $20.13 | 2025 | Mounjaro |
| Kiniksa Pharmaceuticals International, Plc | $16.05 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.